Member Info for Saint68

Hi JHFH. It was indeed a fabulous RNS today for us over at Avacta but I think trying to compare them with Hemo is way off. They went into clinical trials 3 years ago so expect a long delay before we're at that level here - unless CBR is awesome and we get bought out. Also the precision technology is not only aimed at chemotherapy and could be potentially used against other diseases too. As you say, I also think Avacta are way under valued and have now had an upcoming acceleration to phase 2 - missing phase 1B. There will be no phase 3 required there as the drug is a long established agent. I feel we shouldn't draw comparisons between companies that are at very different stages of development.

Bigfatc1_1nt - in the bin with all you other monikers and the other twats.

Rags - please do the board a favour and bin Bill and Wolfie. The board is unreadable between the 3 of you.

Good point Hulver. That explains the differences with the dates. Cheers

It’ll be a tough decision tomorrow.

1. Sell based on the advice and wisdom of random FUD merchants on a BB.

2. Buy more based on information from the likes of Callum, Shaun and the stellar BOD that GGP now have.

I’ll go with option 2.

From the January 9th RNS :

Meanwhile, the Company is conducting in vivo tests to demonstrate that CBR could be used against infectious replicating SARS-CoV-2 virus, including its recent dangerous variants. These tests are being conducted using a biosafety level 3 ("BSL3") facility that belongs to a government-owned institution. BSL3 facilities are used to work with live pathogens that can cause harm to people. It is important to note that this work has not detracted us from our primary focus, and our CAR-T and CDX projects continue to make good progress.

I also assume that if CBR does what it says on the tin then approval could be expedited. Remember that we are testing in US government facilities.

No problem. I must admit that the documents are extremely detailed and trying to decipher what’s happening is very difficult.

Patent approval usually around 2 years from date of 1st filing. Originally filed in March 2022 so approval could be as early as March 2024 - snip from the filing document below. This isn’t set in stone so could be longer.

2-7 Earliest priority application: Filing date 2022-03-01

Great work once again LB and nice to see the company following up on your enquiry. Much appreciated.

Great that the patent details have been published and a nice rise on the back of it but let’s not get carried away just yet. “ It remains to be reviewed and approved by national patent authorities.” - I think when it’s approved we’ll see a pretty decent rise in the SP but until then getting to the raise price would be nice.

Fair enough. Thanks

Gje306 - not sure about this comment "ava6000 could even be used in conjunction with straight dox for delivering a massive dose" . If AVA6000 works as stated surely it would be better to give a massive dose of that ? Am I missing something ?

Ps. You’re in the bin with the rest of the clueless twats.

Just for you LaCucaracha :

CREDIBLE PARTY STILL IN NEGOTIATIONS

SUFFICIENT CASH FOR THE YEAR

NO UPDATE ON NON OWNED DEPOSITS

NEW CEO AFTER SALE OF ASSETS

NYUD – NO FINAL DECISION

COURT CASES – LOGIC – SETTLED. Q+M – CAN’T COMMENT ON ONGOING COURT CASE

NDA’S – VARIABLE AND NEW ONES SIGNED IN JUNE. 1 TO 3 YEAR TIME LINE

ANNUAL REPORT – MUCH TOUGER THIS YEAR – HENCE THE DELAY

OPTIONS – CHURAKOV ‘S CANCELLED

SALE PROCESS – BOD FOCUSSED ON THE SALE – MADE CLEAR MULTIPLE TIMES

JN LEAVING – EPC SPECIALIST SO NOT CURRENTLY NEEDED

NO ROYALTY PAID

DFS – LEGAL PROCEDURES NEED TO BE FOLLOWED BEFORE IT CAN BE PUBLISHED

RESOLUTIONS 6+7 – CRITICAL YEAR. HOPE TO FINALISE THE SALE SO OPTION NEEDS TO BE THERE IN CASE IT’S NEEDED

MT FLANKS – MKT WORK ONGOING

JORC – SUBJECT TO RUSSIAN SYSTEM AND WILL BE PUBLISHED WHEN DFS IS RELEASED

SUBSIDIARIES – MONEY CAPITALISED AS LOANS – PRE-WAR EXPENDITURE. NO INTERUPTIONS TO OPERTAIONS AT ALL IN RUSSIA

AM – VALUED MEMBER OF THE BOARD.

SINOSTEEL – NOT CONSIDERING AS SALE IS WHAT THEY WANT BUT IS STILL AN OPTION

PGM STOCKPILE – WILL BE SOLD

SALE CONFIDENCE – VERY HOPEFUL IT WILL BE COMPLETED THIS YEAR

GOOD RELATIONSHIP WITH RUSSIAN AUTHORITIES – NOT ENCOUNTERED ANY SERIOUS OBJECTIONS AND THEY’RE IMPRESSED WITH THE AUTHORITIES

CS – SIGNIFICANT SHAREHOLDER AND AT 70 YEARS OLD DESERVES A REST.

DIVIDEND – WILL BE PAID UPON SALE OF ASSETS

DRAG LINE PERFORMING VERY WELL AND IS CURRENTLY STOCK PILING ORE AFTER SOME MINOR GLITCHES EARLY ON

SIGNIFICANT SAVINGS BEING MADE USING ELECTRIC

EURASIA V2 – MOVING INTO H2 AND RENEWABLE ENERGY. STILL IN DEVELOPMENT

HANDS TIED WITH RESTRICTIONS REGARDING THE BUYER

LARGE SHAREHOLDERS NO BETTER INFORMED THAN PI’s

NEW CEO TO BE APPOINTED AFTER SALE IS COMPLETED

STILL NOT DIRECTLY AFFECTED BY SANCTIONS

BOD MUST PROTECT TRHE INTERESTS OF ALL SHAREHOLDERS

Strangely they’re up nearly 2% today

JT - the whole off licence thing is a huge grey area. As far as I’m aware AVA6000 would need to finish the STS trial completely to be granted a pharmaceutical product license. Not 100% sure whether FDA accelerated access would have an impact on this though. I can’t see any scenario where use of a drug on trial would be allowed when a licensed version is available. Your Ozempic example would be using a drug with a full PL but using it off label for an unlicensed indication. This happens very often and can be seen a lot with drugs used in children. The MHRA has guidance around unlicensed products - link below.

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1156182/The_supply_of_unlicensed_medicinal_products__special_GN14.pdf

I did warn everyone here when Toffers first started posting that she is an absolute fruit loop but nobody seems to have taken any notice. On the EUA board under multiple aliases and claims that she's a lawyer (probably a 1st class honours from the dole office) and is always banging on about having dialogue with the FCA. Been in my bin for months after claiming that the Russians were going to be using what precious metals EUA have to create shrapnel :-) Please bin here for the BB's sake.

Just a reminder and to keep the clueless in check. Also one more time just for Rick.

CREDIBLE PARTY STILL IN NEGOTIATIONS

SUFFICIENT CASH FOR THE YEAR

NO UPDATE ON NON OWNED DEPOSITS

NEW CEO AFTER SALE OF ASSETS

NYUD – NO FINAL DECISION

COURT CASES – LOGIC – SETTLED. Q+M – CAN’T COMMENT ON ONGOING COURT CASE

NDA’S – VARIABLE AND NEW ONES SIGNED IN JUNE. 1 TO 3 YEAR TIME LINE

ANNUAL REPORT – MUCH TOUGER THIS YEAR – HENCE THE DELAY

OPTIONS – CHURAKOV ‘S CANCELLED

SALE PROCESS – BOD FOCUSSED ON THE SALE – MADE CLEAR MULTIPLE TIMES

JN LEAVING – EPC SPECIALIST SO NOT CURRENTLY NEEDED

NO ROYALTY PAID

DFS – LEGAL PROCEDURES NEED TO BE FOLLOWED BEFORE IT CAN BE PUBLISHED

RESOLUTIONS 6+7 – CRITICAL YEAR. HOPE TO FINALISE THE SALE SO OPTION NEEDS TO BE THERE IN CASE IT’S NEEDED

MT FLANKS – MKT WORK ONGOING

JORC – SUBJECT TO RUSSIAN SYSTEM AND WILL BE PUBLISHED WHEN DFS IS RELEASED

SUBSIDIARIES – MONEY CAPITALISED AS LOANS – PRE-WAR EXPENDITURE. NO INTERUPTIONS TO OPERTAIONS AT ALL IN RUSSIA

AM – VALUED MEMBER OF THE BOARD.

SINOSTEEL – NOT CONSIDERING AS SALE IS WHAT THEY WANT BUT IS STILL AN OPTION

PGM STOCKPILE – WILL BE SOLD

SALE CONFIDENCE – VERY HOPEFUL IT WILL BE COMPLETED THIS YEAR

GOOD RELATIONSHIP WITH RUSSIAN AUTHORITIES – NOT ENCOUNTERED ANY SERIOUS OBJECTIONS AND THEY’RE IMPRESSED WITH THE AUTHORITIES

CS – SIGNIFICANT SHAREHOLDER AND AT 70 YEARS OLD DESERVES A REST.

DIVIDEND – WILL BE PAID UPON SALE OF ASSETS

DRAG LINE PERFORMING VERY WELL AND IS CURRENTLY STOCK PILING ORE AFTER SOME MINOR GLITCHES EARLY ON

SIGNIFICANT SAVINGS BEING MADE USING ELECTRIC

EURASIA V2 – MOVING INTO H2 AND RENEWABLE ENERGY. STILL IN DEVELOPMENT

HANDS TIED WITH RESTRICTIONS REGARDING THE BUYER

LARGE SHAREHOLDERS NO BETTER INFORMED THAN PI’s

NEW CEO TO BE APPOINTED AFTER SALE IS COMPLETED

STILL NOT DIRECTLY AFFECTED BY SANCTIONS

BOD MUST PROTECT TRHE INTERESTS OF ALL SHAREHOLDERS

Lenoman - that's brilliant. If you're reading this Rick check out the list of filters I just posted. As you can see you are somewhere in the middle so haven't read any of your b0ll0x for months and have no intention of changing that.